Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001649094-24-000097
Filing Date
2024-11-05
Accepted
2024-11-05 16:05:32
Documents
80
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q pcvx-20240930.htm   iXBRL 10-Q 1785033
2 EX-31.1 pcvx-20240930x10qxexx311.htm EX-31.1 10553
3 EX-31.2 pcvx-20240930x10qxexx312.htm EX-31.2 10564
4 EX-32.1 pcvx-20240930x10qxexx321.htm EX-32.1 7146
  Complete submission text file 0001649094-24-000097.txt   7887051

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcvx-20240930.xsd EX-101.SCH 61802
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcvx-20240930_cal.xml EX-101.CAL 79327
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcvx-20240930_def.xml EX-101.DEF 243170
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcvx-20240930_lab.xml EX-101.LAB 692674
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcvx-20240930_pre.xml EX-101.PRE 477626
83 EXTRACTED XBRL INSTANCE DOCUMENT pcvx-20240930_htm.xml XML 995395
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

EIN.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39323 | Film No.: 241427429
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)